BA
IDIX

BlackRock Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

BlackRock Advisors’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-125,101
Closed -$3.02M – 3792
2014
Q2 		$3.02M Buy
125,101
+46,784
+60% +$488K ﹤0.01% 1077
2014
Q1 		$472K Buy
78,317
+11,288
+17% +$78.7K ﹤0.01% 2084
2013
Q4 		$401K Buy
67,029
+5,625
+9% +$26K ﹤0.01% 2197
2013
Q3 		$319K Buy
61,404
+1,640
+3% +$7.19K ﹤0.01% 2240
2013
Q2 		$216K Buy
+59,764
New +$244K ﹤0.01% 2425

BlackRock Advisors's IDIX Position: Q3 2014 in Review

BlackRock Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 125,101 shares — an estimated $3.02M sold.

BlackRock Advisors first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $3.02M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • BlackRock Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • BlackRock Advisors sold 125,101 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $3.02M.
  • BlackRock Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • BlackRock Advisors's IDENIX PHARMACEUTICALS INC position peaked at $3.02M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on BlackRock Advisors's 13F filing for Q3 2014, filed 29 Oct 2014.